Evidence map›Paper›PMID 31181853›Full record

ArticlePolymers2019

Polymeric Composites with Silver (I) Cyanoximates Inhibit Biofilm Formation of Gram-Positive and Gram-Negative Bacteria.

S R Lotlikar, E Gallaway, T Grant, S Popis, M Whited, M Guragain, R Rogers, S Hamilton, N G Gerasimchuk, M A Patrauchan

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Partial in-vitro dispersal ofmicroPublication biology · 2024
    Article
  4. Article
  5. Article
  6. Microbiology (Reading, England) · 2021
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

S R LotlikarDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078, USA. Shalaka.l@gmail.com.
E GallawayDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078, USA. erin.gallaway@okstate.edu.
T GrantDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078, USA. treyon@ostatemail.okstate.edu.
S PopisDepartment of Chemistry, Missouri State University, Springfield, MO 65897, USA. Snow87@live.missouristate.edu.
M WhitedDepartment of Chemistry, Missouri State University, Springfield, MO 65897, USA. ger.nick@live.com.
M GuragainDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078, USA. manita.guragain@usda.gov.
R RogersDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078, USA. rendirogers@gmail.com.
S HamiltonDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078, USA. jsarahd@okstate.edu.
N G GerasimchukDepartment of Chemistry, Missouri State University, Springfield, MO 65897, USA. NNGerasimchuk@MissouriState.edu.
M A PatrauchanDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078, USA. m.patrauchan@okstate.edu.
Oklahoma State University · USMissouri State University · US

Funding

Cottrell College Research Corporation CC 6598NIAID NIH HHS HHSN272200700055CNIH HHS 1R15AI088594-01A1
6 · The paper itself

Abstract

Biofilms are surface-associated microbial communities known for their increased resistance to antimicrobials and host factors. This resistance introduces a critical clinical challenge, particularly in cases associated with implants increasing the predisposition for bacterial infections. Preventing such infections requires the development of novel antimicrobials or compounds that enhance bactericidal effect of currently available antibiotics. We have synthesized and characterized twelve novel silver(I) cyanoximates designated as Ag(ACO), Ag(BCO), Ag(CCO), Ag(ECO), Ag(PiCO), Ag(PICO) (yellow and red polymorphs), Ag(BIHCO), Ag(BIMCO), Ag(BOCO), Ag(BTCO), Ag(MCO) and Ag(PiPCO). The compounds exhibit a remarkable resistance to high intensity visible light, UV radiation and heat and have poor solubility in water. All these compounds can be well incorporated into the light-curable acrylate polymeric composites that are currently used as dental fillers or adhesives of indwelling medical devices. A range of dry weight % from 0.5 to 5.0 of the compounds was tested in this study. To study the potential of these compounds in preventing planktonic and biofilm growth of bacteria, we selected two human pathogens (Gram-negative

Indexed as

Biofilm, antimicrobialcyanoximesdensity and porosityleaching studiesmechanical strengthpolymeric compositesPseudomonas aeruginosaSilver (I) coordination polymersStaphylococcus aureusthermal stability

Identifiers

PMID31181853
PMCPMC6631325
OpenAlexW2948778628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.